Bronchopulmonary involvement in severe cutaneous adverse reactions

被引:1
作者
de Prost, N. [1 ]
Mekontso-Dessap, A. [1 ]
Valeyrie-Allanore, L. [2 ,3 ]
Maitre, B. [4 ]
机构
[1] Hop Henri Mondor, AP HP, Serv Reanimat Med, 51 Ave Marechal Lattre Tassigny, F-94010 Creteil, France
[2] Hop Henri Mondor, AP HP, Serv Dermatol, Creteil, France
[3] Hop Henri Mondor, AP HP, Ctr Reference Maladies Bulleuses Immunol & Tox, Creteil, France
[4] Hop Henri Mondor, AP HP, Serv Animat Med, Antenne Pneumol, Creteil, France
来源
REANIMATION | 2013年 / 22卷 / 01期
关键词
Stevens-Johnson syndrome; Toxic epidermal necrolysis; Severe cutaneous adverse reaction; DRESS; Acute respiratory distress syndrome;
D O I
10.1007/s13546-012-0522-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Skin is one of the most common targets of adverse drug reactions. Life-threatening skin adverse reactions include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS). SJS and TEN are characterized by skin and mucous membrane detachments. Respiratory complications occur in about 40% of the cases, and can be related to specific bronchial epithelial injuries as well as to nonspecific manifestations like infection, pulmonary edema, and atelectasis. Mechanical ventilation is required in about 25% of cases. Bronchoscopy is warranted in mechanically ventilated patients to remove detached mucous membranes and prevent airway obstruction. Pulmonary involvement in DRESS is rare and related to lung infiltration by eosinophils, which rarely leads to the acute respiratory distress syndrome. The most severe cases of DRESS usually present other organ involvement like cytolytic hepatitis and are usually reversible after steroid treatment. Removal of the involved drug is warranted.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 47 条
[1]  
Angel-Moreno-Maroto Alfonso, 2006, J Infect, V52, pe39, DOI 10.1016/j.jinf.2005.05.020
[2]   Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis - A prospective noncomparative study showing no benefit on mortality or progression [J].
Bachot, N ;
Revuz, J ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :33-36
[3]   SCORTEN: A severity-of-illness score for toxic epidermal necrolysis [J].
Bastuji-Garin, S ;
Fouchard, N ;
Bertocchi, M ;
Roujeau, JC ;
Revuz, J ;
Wolkenstein, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :149-153
[4]   CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96
[5]   Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) [J].
Bocquet, H ;
Bagot, M ;
Roujeau, JC .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1996, 15 (04) :250-257
[6]   The DRESS Syndrome: A Literature Review [J].
Cacoub, Patrice ;
Musette, Philippe ;
Descamps, Vincent ;
Meyer, Olivier ;
Speirs, Chris ;
Finzi, Laetitia ;
Roujeau, Jean Claude .
AMERICAN JOURNAL OF MEDICINE, 2011, 124 (07) :588-597
[7]   INTESTINAL INVOLVEMENT IN DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS [J].
CHOSIDOW, O ;
DELCHIER, JC ;
CHAUMETTE, MT ;
WECHSLER, J ;
WOLKENSTEIN, P ;
BOURGAULT, I ;
ROUJEAU, JC ;
REVUZ, J .
LANCET, 1991, 337 (8746) :928-928
[8]   A marker for Stevens-Johnson syndrome [J].
Chung, WH ;
Hung, SI ;
Hong, HS ;
Hsih, MS ;
Yang, LC ;
Ho, HC ;
Wu, JY ;
Chen, YT .
NATURE, 2004, 428 (6982) :486-486
[9]  
de Prost N, 2012, REANIMATION, V21, pS108
[10]   Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Epidemiology, Risk Factors, and Predictive Value of Skin Cultures [J].
de Prost, Nicolas ;
Ingen-Housz-Oro, Saskia ;
Duong, Tu Anh ;
Valeyrie-Allanore, Laurence ;
Legrand, Patrick ;
Wolkenstein, Pierre ;
Brochard, Laurent ;
Brun-Buisson, Christian ;
Roujeau, Jean-Claude .
MEDICINE, 2010, 89 (01) :28-36